Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Metabolic Syndrome × Observation × Clear all

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 19 Prostatic Neoplasms 18 Carcinoma, Non-Small-Cell Lung 16 Neoplasms 15 Endometrial Neoplasms 13 Colorectal Neoplasms 12 Stomach Neoplasms 11 Lung Neoplasms 11 Pancreatic Neoplasms 9 Carcinoma, Hepatocellular 7 Oropharyngeal Neoplasms 6 Multiple Myeloma 6 Lymphoma, Large B-Cell, Diffuse 6 Leukemia, Myeloid, Acute 6 Esophageal Neoplasms 6 Colonic Neoplasms 6 Sarcoma 5 Neoplasm Metastasis 5 Mouth Neoplasms 5 Melanoma 5 Uterine Cervical Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Recurrence 4 Head and Neck Neoplasms 4 Colorectal Neoplasms, Hereditary Nonpolyposis 4 Brain Neoplasms 4 Anus Neoplasms 4 Urinary Bladder Neoplasms 3 Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3

Interventions

Metformin 7 Pioglitazone 2 Magnetic Resonance Spectroscopy 2 Inositol 2 Exercise 2 Blood Pressure 2 semaglutide 1 maltodextrin 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1 Walking 1 Vascular Stiffness 1 Triptorelin Pamoate 1 Topiramate 1 Tirzepatide 1 Testosterone 1 Spironolactone 1 Qsymia 1 Pyruvic Acid 1 Pulse Wave Analysis 1 Phlebotomy 1 Phentermine 1 Pancreaticoduodenectomy 1 Orchiectomy 1 Observation 1 Naltrexone 1 Medical History Taking 1 Liraglutide 1 Leuprolide 1 Human Growth Hormone 1 Hepatectomy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07094776 2025-08-06

PCOSMG53

Gaziosmanpasa Research and Education Hospital

Enrolling by invitation

Insulin Resistance, Polycystic Ovary Syndrome, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡